Glaukos CorporationNYSE: GKOS

Third Quarter 2026 GAAP to Non-GAAP Recs

· Issued by Glaukos Corporation

Key figures

  • Mobius acquisition-related amortization expense of developed intellectual property of $0.5 million in Q3 2026 and Q3 2025, respectively.
  • Non-recurring, non-cash charge related to the write-down of certain inventory of $1.3 million.
  • Expenses of $5.9 million related to the Company's trade secrets lit igation and other litigation matters.
  • Expense of $14.1 million related to the resolution agreement with the Regents of the University of California.
  • Expenses of $0.8 million associated with the integration of a major system.

On 6ix: 6ix.com/news/glaukos-third-quarter-2026-gaap-to-non-gaap-recs

GAAP to Non-GAAP Reconciliations

(in thousands, except per share amounts and percentage data)

(unaudited)

Q 3 2026

Q 3 2025

GAAP

Adjustments

Non-GAAP

GAAP

Adjustments

Non-GAAP

Cost of sales

$ 31,164

$ (5,274) (A)

$ 25,890

$ 28,831

$ (7,310) (A)(B)

$ 21,521

Gross Margin

85.2%

2.5%

87.7%

78.4%

5.5%

83.9%

Operating expenses:

Selling, general and administrative

$ 130,943

$ (21,219) (C)(D)

$ 109,724

$ 82,999

$ 243 (D)

$ 83,242

Income (loss) from operations

$ 828

$ 26,493

$ 27,321

$ (16,365)

$ 7,067

$ (9,298)

Net income (loss)

$ 2,018

$ 26,493

(E)

$ 28,511

$ (16,231)

$ 7,067

(E)

$ (9,164)

Basic net income (loss) per share

$ 0.03

$ 0.45

$ 0.48

$ (0.28)

$ 0.12

$ (0.16)

Diluted net income (loss) per share

$ 0.03

$ 0.44

$ 0.47

$ (0.28)

$ 0.12

$ (0.16)

Weighted-average shares outstanding used to

compute basic net income (loss) per share

59,105

59,105

57,398

57,398

Weighted-average shares outstanding used to

compute diluted net income (loss) per share

61,196

61,196

57,398

57,398

(A)

  • Cost of sales adjustment related to amortization of developed technology intangible assets associated with the acquisition of Avedro, Inc. (Avedro) of $4.8 million in Q3 2026 and $5.5 million in Q3 2025.

  • Mobius acquisition-related amortization expense of developed intellectual property of $0.5 million in Q3 2026 and Q3 2025, respectively.

    (B)

  • Non-recurring, non-cash charge related to the write-down of certain inventory of $1.3 million.

    (C)

  • Expenses of $5.9 million related to the Company's trade secrets lit igation and other litigation matters.

  • Expense of $14.1 million related to the resolution agreement with the Regents of the University of California.

  • Expenses of $0.8 million associated with the integration of a major system.

    (D)

  • Mobius contingent consideration fair value adjustments of $0.4 million in Q3 2026 and ($0.2) million in Q3 2025.

    (E)

  • Includes total tax effect for non-GAAP pre-tax adjustments. For non-GAAP adjustments associated with the U.S., the tax effect is $0 given the Company's U.S. taxable loss positions in both 2026 and 2025.

    GAAP to Non-GAAP Reconciliations

    (in thousands, except pe r share amounts and percentage data) (unaudited)

    Year-to-Date Q 3 2026

Year-to-Date Q 3 2025

GAAP

Adjustments

Non-GAAP

GAAP

Adjustments

Non-GAAP

Cost of sales

$ 98,519

$ (19,222)

(A)

$ 79,297

$ 80,043

$ (18,597)

(A)(B)

$ 61,446

Gross Margin

82.0%

3.5%

85.5%

78.0%

5.1%

83.1%

Operating expenses:

Selling, general and administrative

$ 339,946

$ (26,316)

(C)(D)

$ 313,630

$ 237,047

$ (52)

(D)

$ 236,995

(Loss) income from operations

$ (36,295)

$ 45,538

$ 9,243

$ (59,732)

$ 18,649

$ (41,083)

Non-operating income (expense):

Interest expense

$ (3,671)

$ 369

(E)

$ (3,302)

$ (3,489)

$ -

$ (3,489)

Net (loss) income

$ (36,142)

$ 45,907

(F)

$ 9,765

$ (54,034)

$ 18,649

(F)

$ (35,385)

Basic net (loss) income per share

$ (0.62)

$ 0.79

$ 0.17

$ (0.95)

$ 0.33

$ (0.62)

Diluted net (loss) income per share

$ (0.62)

$ 0.78

$ 0.16

$ (0.95)

$ 0.33

$ (0.62)

Weighted-average shares outstanding used to

compute basic net income (loss) per share

58,651

58,651

57,083

57,083

Weighted-average shares outstanding used to

compute diluted net income (loss) per share (G)

58,651

60,598

57,083

57,083

(A)

  • Cost of sales adjustment related to amortization of developed technology intangible assets associated with the acquisition of Avedro, Inc. (Avedro) of $17.8 million year-to-date Q3 2026 and $16.6 million year-to-date Q3 2025.

  • Mobius acquisition-related amortization expense of developed intellectual property of $1.5 million year-to-date Q3 2026 and $0.7 million year-to-date Q3 2025.

    (B)

  • Non-recurring, non-cash charge related to the write-down of certain inventory of $1.3 million.

    (C)

  • Expenses of $9.9 million related to the Company's trade secrets litigation and other lit igation matters.

  • Expense of $14.1 million related to the resolution agreement with the Regents of the University of California.

  • Expenses of $1.2 million associated with the integration of a major system.

  • Provision for doubtful accounts related to the overpayment of prior period payroll withholdings of $0.7 million.

    (D)

  • Mobius contingent consideration fair value adjustments of $0.4 million year-to-date Q3 2026 and ($0.2) million year-to-date Q3 2025.

  • Mobius acquisition-related transaction expense of $0.3 million year-to-date Q3 2025.

    (E)

  • Interest expense related to the untimely payment of prior period payroll withholdings.

    (F)

  • Includes total tax effect for non-GAAP pre-tax adjustments. For non-GAAP adjustments associated with the U.S., the tax effect is $0 given the Company's U.S. taxable loss positions in both 2026 and 2025.

    (G)

  • Year-to-date Q3 2026 non-GAAP diluted weighted-average shares reflect the dilution effect from outstanding stock options, unvested

restricted stock units, performance-based equity awards, and employee stock purchase program option shares under the treasury stock method.

Glaukos Corporation on 6ix

Earlier from Glaukos

Later from Glaukos

All Glaukos news releases